Literature DB >> 9538483

An audit of prostate-specific antigen and clinical symptoms in general practice.

S Ramachandran1, M C Foster, D R Thomas, A K Roalfe, R A Hall.   

Abstract

The objective was to devise local guidelines for the referral of patients with suspected prostatic carcinoma following evaluation by a retrospective audit of the value of the prostate-specific antigen concentration, together with age, urological symptoms, and digital rectal examination in the diagnosis of carcinoma of the prostate. Relevant details were collected from the notes of 582 patients from general practice and hospital. The significant diagnostic factors were ascertained by stepwise logistic regression. Prostate-specific antigen concentration, digital rectal examination and significant terminal dribbling were the most powerful factors in the diagnosis of carcinoma of the prostate. When prostate-specific antigen concentration was considered in isolation, a value of 6.5 ng/ml appeared appropriate for referral. Age was not significant, perhaps due to the narrow patient age range. The significant diagnostic factors were built into an algorithm calculating the probability of carcinoma of the prostate. This algorithm, together with prostate-specific antigen concentration results and digital rectal examination findings, forms the basis of the referral guidelines and a subsequent prospective study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538483      PMCID: PMC2360786          DOI: 10.1136/pgmj.74.867.28

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Interexaminer variability of digital rectal examination in detecting prostate cancer.

Authors:  D S Smith; W J Catalona
Journal:  Urology       Date:  1995-01       Impact factor: 2.649

2.  The value of serum prostate specific antigen determinations before and after radical prostatectomy.

Authors:  P H Lange; C J Ercole; D J Lightner; E E Fraley; R Vessella
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

3.  A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

Authors:  H Lilja
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

4.  Clinical use of prostate specific antigen in patients with prostate cancer.

Authors:  M A Hudson; R R Bahnson; W J Catalona
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

Review 5.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

6.  Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.

Authors:  J P Gaddipati; D G McLeod; H B Heidenberg; I A Sesterhenn; M J Finger; J W Moul; S Srivastava
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

7.  Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.

Authors:  H Lilja; J Oldbring; G Rannevik; C B Laurell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

8.  Influence of patient age on the serum PSA concentration. An important clinical observation.

Authors:  J E Oesterling; W H Cooner; S J Jacobsen; H A Guess; M M Lieber
Journal:  Urol Clin North Am       Date:  1993-11       Impact factor: 2.241

9.  Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario.

Authors:  W J Glenski; R S Malek; J F Myrtle; J E Oesterling
Journal:  Mayo Clin Proc       Date:  1992-03       Impact factor: 7.616

Review 10.  Prostate-specific antigen: biochemistry, analytical methods, and clinical application.

Authors:  D A Armbruster
Journal:  Clin Chem       Date:  1993-02       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.